Development Level

Tclin 2 | 602

Disease

Duodenal Ulcer due to H. Pylori 2 | 7
Duodenal ulcer disease 2 | 7
Erosive esophagitis 2 | 6
Gastric Hypersecretory Conditions 2 | 5
Gastric ulcer 2 | 34
Gastritis 2 | 44
Gastro-esophageal reflux disease with esophagitis 2 | 3
Gastroesophageal reflux disease 2 | 37
Maintenance of Healing Duodenal Ulcer 2 | 7
Maintenance of Healing Erosive Esophagitis 2 | 2
Maintenance of Healing Gastroesophageal Reflux 2 | 2
Multiple endocrine adenomas 2 | 3
NSAID-Induced Gastric Ulcer 2 | 4
Osteoarthritis in Patients at High Ulcer Risk 2 | 7
Pathological Gastric Hypersecretory Condition 2 | 2
Peptic reflux disease 2 | 4
Peptic ulcer 2 | 22
Prevention of NSAID-Induced Gastric Ulcer 2 | 3
Rheumatoid Arthritis in Patient at High Ulcer Risk 2 | 7
Systemic mast cell disease 2 | 12
Zollinger-Ellison Syndrome 2 | 14
Achalasia 1 | 11
Allergic hypersensitivity disease 1 | 123
Anemia 1 | 252
Arthritis 1 | 248
Asthma 1 | 349
Barrett's esophagus 1 | 183
Bile reflux 1 | 8
Cancer 1 | 2,346
Carcinoma 1 | 2,147
Cerebrovascular disease 1 | 231
Chronic intestinal vascular insufficiency 1 | 12
Constipation 1 | 43
Coronary artery disease 1 | 240
Diarrhea 1 | 155
Duodenitis 1 | 8
Duodenogastric reflux 1 | 8
Dyskinesia of esophagus 1 | 3
Dyspepsia 1 | 34
Eosinophilia 1 | 65
Esophageal atresia 1 | 25
Esophageal varix 1 | 10
Esophagitis 1 | 26
Gastric antral vascular ectasia 1 | 11
Gastric outlet obstruction 1 | 6
Gastroenteritis 1 | 46
Gastroparesis 1 | 20
Hiatus hernia 1 | 7
Hypersensitivity reaction type II disease 1 | 235
Inflammatory bowel disease 1 | 142
Irritable bowel syndrome 1 | 59
Kidney disease 1 | 396
Laryngitis 1 | 2
Liver disease 1 | 219
Osteopetrosis 1 | 40
Osteoporosis 1 | 257
Pain disorder 1 | 13
Peptic ulcer disease 1 | 11
Peritonitis 1 | 37
Pernicious anemia 1 | 10
Pneumonia 1 | 133
Varicose veins 1 | 15
Vitamin B12 deficiency 1 | 20
X-linked myopathy with excessive autophagy 1 | 2
diabetes mellitus 1 | 1,663
intraductal papillary-mucinous adenoma (IPMA) 1 | 2,956
intraductal papillary-mucinous neoplasm (IPMN) 1 | 3,289
ovarian cancer 1 | 8,484
pancreatic cancer 1 | 2,300
posterior fossa group B ependymoma 1 | 1,530

Tissue

Blood and immune system 2 | 17,995
Cardiovascular System 2 | 17,958
Digestive Tract 2 | 18,473
Endocrine System 2 | 18,512
Female tissues 2 | 18,647
Liver and Pancreas 2 | 18,136
Male tissues 2 | 17,969
Nervous System 2 | 18,561
Respiratory system 2 | 17,484
Skin and soft tissues 2 | 18,115
Urinary Tract 2 | 18,444

Target Family

Transporter 2 | 473

PathwayCommons: smpdb Pathway

Lansoprazole Metabolism Pathwa... 2 | 2
Phenytoin (Antiarrhythmic) Act... 79 | 79
Lidocaine (Antiarrhythmic) Act... 61 | 61
Carvedilol Action Pathway 60 | 60
Labetalol Action Pathway 60 | 60
Muscle/Heart Contraction 60 | 60
Acebutolol Action Pathway 59 | 59
Alprenolol Action Pathway 59 | 59
Amiodarone Action Pathway 59 | 59
Amlodipine Action Pathway 59 | 59
Arbutamine Action Pathway 59 | 59
Atenolol Action Pathway 59 | 59
Betaxolol Action Pathway 59 | 59
Bevantolol Action Pathway 59 | 59
Bisoprolol Action Pathway 59 | 59
Bopindolol Action Pathway 59 | 59
Bupranolol Action Pathway 59 | 59
Carteolol Action Pathway 59 | 59
Diltiazem Action Pathway 59 | 59
Disopyramide Action Pathway 59 | 59
Dobutamine Action Pathway 59 | 59
Epinephrine Action Pathway 59 | 59
Esmolol Action Pathway 59 | 59
Felodipine Action Pathway 59 | 59
Flecainide Action Pathway 59 | 59
Fosphenytoin (Antiarrhythmic) ... 59 | 59
Ibutilide Action Pathway 59 | 59
Isoprenaline Action Pathway 59 | 59
Isradipine Action Pathway 59 | 59
Levobunolol Action Pathway 59 | 59
Metipranolol Action Pathway 59 | 59
Metoprolol Action Pathway 59 | 59
Mexiletine Action Pathway 59 | 59
Nadolol Action Pathway 59 | 59
Nebivolol Action Pathway 59 | 59
Nifedipine Action Pathway 59 | 59
Nimodipine Action Pathway 59 | 59
Nisoldipine Action Pathway 59 | 59
Nitrendipine Action Pathway 59 | 59
Oxprenolol Action Pathway 59 | 59
Penbutolol Action Pathway 59 | 59
Pindolol Action Pathway 59 | 59
Practolol Action Pathway 59 | 59
Procainamide (Antiarrhythmic) ... 59 | 59
Propranolol Action Pathway 59 | 59
Quinidine Action Pathway 59 | 59
Sotalol Action Pathway 59 | 59
Timolol Action Pathway 59 | 59
Tocainide Action Pathway 59 | 59
Verapamil Action Pathway 59 | 59
Azathioprine Action Pathway 47 | 47
Ibuprofen Action Pathway 47 | 47
Mercaptopurine Action Pathway 47 | 47
Thioguanine Action Pathway 47 | 47
Warburg Effect 45 | 45
Intracellular Signalling Throu... 38 | 38
AICA-Ribosiduria 37 | 37
Adenine phosphoribosyltransfer... 37 | 37
Adenosine Deaminase Deficiency 37 | 37
Adenylosuccinate Lyase Deficie... 37 | 37
Gout or Kelley-Seegmiller Synd... 37 | 37
Intracellular Signalling Throu... 37 | 37
Lesch-Nyhan Syndrome (LNS) 37 | 37
Mitochondrial DNA depletion sy... 37 | 37
Molybdenum Cofactor Deficiency 37 | 37
Myoadenylate deaminase deficie... 37 | 37
Purine Metabolism 37 | 37
Purine Nucleoside Phosphorylas... 37 | 37
Xanthine Dehydrogenase Deficie... 37 | 37
Xanthinuria type I 37 | 37
Xanthinuria type II 37 | 37
Fc Epsilon Receptor I Signalin... 36 | 36
Morphine Action Pathway 35 | 35
Retinol Metabolism 35 | 35
Vitamin A Deficiency 35 | 35
Celecoxib Action Pathway 34 | 34
Eplerenone Action Pathway 33 | 33
Spironolactone Action Pathway 33 | 33
Amiloride Action Pathway 32 | 32
Bendroflumethiazide Action Pat... 32 | 32
Blue diaper syndrome 32 | 32
Bumetanide Action Pathway 32 | 32
Chlorothiazide Action Pathway 32 | 32
Chlorthalidone Action Pathway 32 | 32
Cyclothiazide Action Pathway 32 | 32
Cystinuria 32 | 32
Ethacrynic Acid Action Pathway 32 | 32
Furosemide Action Pathway 32 | 32
Glucose Transporter Defect (SG... 32 | 32
Hartnup Disorder 32 | 32
Hydrochlorothiazide Action Pat... 32 | 32
Hydroflumethiazide Action Path... 32 | 32
Iminoglycinuria 32 | 32
Indapamide Action Pathway 32 | 32
Kidney Function 32 | 32
Lysinuric Protein Intolerance 32 | 32
Lysinuric protein intolerance ... 32 | 32
Methyclothiazide Action Pathwa... 32 | 32
Metolazone Action Pathway 32 | 32
Polythiazide Action Pathway 32 | 32
Quinethazone Action Pathway 32 | 32

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Potassium-transporting ATPase subunit beta ATP4B Tclin Transporter -0.76953 6.01 159
Potassium-transporting ATPase alpha chain 1 ATP4A Tclin Transporter -3.77806 5994.1 21